Código QR (código de barras bidimensional)

Liquid Biopsy in Early Screening of Cancers: Emerging Technologies and New Prospects

Liquid biopsy is moving beyond mutation-centric assays to multimodal frameworks that integrate cell-free DNA (cfDNA) signals with additional analytes such as circulating tumor cells (CTCs) and extracellular vesicles (EVs). In this review, we summarize emerging technologies across analytes for early...

תיאור מלא

שמור ב:
Principais autores: Hanyu Zhu, Zhenyu Li, Kunxin Xie, Sajjaad Hassan Kassim, Cheng Cao, Keyu Huang, Zipeng Lu, Chenshan Ma, Ying Li, Kuirong Jiang, Lingdi Yin
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI AG 2026-01-01
סדרה:Biomedicines
נושאים:
liquid biopsy
cfDNA
CTCs
fragmentomics
multimodal AI
MCED
גישה מקוונת:https://www.mdpi.com/2227-9059/14/1/158
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים